Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 04-Oct-23 5:06 PM View:  | Clearside Biomedical, Inc. (CLSD) | 03-Oct-23 | Private Purchase | 10,000 | $0.86 | $8,600.00 | 12% 83.0K to 93.0K | |
| 15-Jun-23 4:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Jun-23 | Sale | 12,866 | $8.04 | $103,443.00 | (14%) 94.68K to 81.82K | |
| 15-Jun-23 4:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Grant | 16,745 | -- | -- | 21% 77.94K to 94.68K | |
| 19-May-23 4:15 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 19-May-23 | Option Exercise | 3,750 | -- | -- | 10% 37.76K to 41.51K | |
| 21-Nov-22 8:12 AM View: | Clearside Biomedical, Inc. (CLSD) | 17-Nov-22 | Private Purchase | 30,000 | $1.33 | $39,900.00 | 57% 53.0K to 83.0K | |
| 09-Jun-22 4:48 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 07-Jun-22 | Grant | 12,866 | -- | -- | 20% 65.07K to 77.94K | |
| 08-Nov-21 6:26 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 08-Nov-21 | Option Exercise | 7,400 | $3.15 | $23,310.00 | 28% 26.36K to 33.76K | |
| 08-Nov-21 6:26 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 05-Nov-21 | Option Exercise | 26,360 | $2.31 | $60,908.60 | 100% 0 to 26.36K | |
| 02-Nov-21 4:40 PM View: | Clearside Biomedical, Inc. (CLSD) | 29-Oct-21 | Option Exercise | 40,000 | $2.03 | $81,350.00 | 308% 13.0K to 53.0K | |
| 19-Oct-21 4:21 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Oct-21 | Option Exercise | 105,000 | $3.46 | $363,450.00 | 161% 65.07K to 170.07K | |
| 19-Oct-21 4:21 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Oct-21 | Market Option Sale | 105,000 | $15.40 | $1,617,000.00 | (62%) 170.07K to 65.07K | |
| 19-Aug-21 4:24 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 18-Aug-21 | Market Purchase | 3,000 | $3.08 | $9,240.00 | 300% 1.0K to 4.0K | (2%) |
| 17-Aug-21 10:00 PM View: | Clearside Biomedical, Inc. (CLSD) | 16-Aug-21 | Market Purchase | 3,000 | $5.68 | $17,040.00 | 30% 10.0K to 13.0K | (7%) |
| 15-Jun-21 4:06 PM View: | Endo International plc (ENDP) | 11-Jun-21 | Grant | 47,924 | -- | -- | 53% 91.22K to 139.14K | |
| 15-Jun-21 4:06 PM View: | Endo International plc (ENDP) | 11-Jun-21 | Payment of Exercise | 23,003 | $6.26 | $143,999.00 | (17%) 139.14K to 116.14K | |
| 14-Jun-21 4:29 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-Jun-21 | Option Exercise | 23,333 | $3.15 | $73,549.00 | 36% 65.07K to 88.41K | |
| 14-Jun-21 4:29 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 10-Jun-21 | Market Option Sale | 23,333 | $16.86 | $393,394.00 | (26%) 88.41K to 65.07K | |
| 01-Jun-21 4:24 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-May-21 | Grant | 317 | $15.77 | $4,999.09 | < 1% 64.76K to 65.07K | 0% |
| 15-Mar-21 4:50 PM View: | Clearside Biomedical, Inc. (CLSD) | 12-Mar-21 | Market Purchase | 5,000 | $3.11 | $15,525.00 | 100% 5.0K to 10.0K | (17%) |
| 02-Mar-21 4:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 26-Feb-21 | Grant | 463 | $10.78 | $4,991.14 | < 1% 64.29K to 64.76K | 11% |
| 02-Dec-20 4:16 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 30-Nov-20 | Grant | 978 | $5.11 | $4,997.58 | 2% 63.31K to 64.29K | 49% |
| 02-Sep-20 4:44 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-Aug-20 | Grant | 1,204 | $4.15 | $4,996.60 | 2% 62.11K to 63.31K | 83% |
| 16-Jun-20 4:06 PM View: | Endo International plc (ENDP) | 12-Jun-20 | Grant | 25,511 | -- | -- | 33% 77.95K to 103.46K | |
| 16-Jun-20 4:06 PM View: | Endo International plc (ENDP) | 12-Jun-20 | Payment of Exercise | 12,245 | $3.43 | $42,000.40 | (12%) 103.46K to 91.22K | (113%) |
| 03-Jun-20 4:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-20 | Grant | 2,224 | $4.49 | $9,996.88 | 4% 59.89K to 62.11K | 69% |
| 21-May-20 4:50 PM View: | Clearside Biomedical, Inc. (CLSD) | 20-May-20 | Market Purchase | 5,000 | $1.85 | $9,250.00 | 100% 0 to 5.0K | 39% |
| 03-Mar-20 4:50 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-20 | Grant | 3,333 | $3.00 | $9,999.00 | 6% 56.55K to 59.89K | 151% |
| 03-Dec-19 5:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-19 | Grant | 3,508 | $2.85 | $9,997.80 | 7% 53.05K to 56.55K | 163% |
| 18-Nov-19 4:10 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Nov-19 | Private Purchase | 10,000 | $1.45 | $14,500.00 | 23% 43.05K to 53.05K | |
| 04-Sep-19 4:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-19 | Grant | 3,344 | $2.99 | $9,998.56 | 8% 39.7K to 43.05K | 152% |
| 14-Jun-19 7:30 PM View: | Endo International plc (ENDP) | 12-Jun-19 | Grant | 53,812 | -- | -- | 108% 49.97K to 103.78K | |
| 14-Jun-19 7:30 PM View: | Endo International plc (ENDP) | 12-Jun-19 | Payment of Exercise | 25,829 | $4.46 | $115,197.00 | (25%) 103.78K to 77.95K | (63%) |
| 17-Dec-18 4:19 PM View: | Phasebio Pharmaceuticals Inc (PHAS) | 17-Dec-18 | Purchase | 1,000 | $4.46 | $4,460.00 | 100% 0 to 1.0K | |
| 16-Nov-18 4:03 PM View: | Endo International plc (ENDP) | 15-Nov-18 | Market Sale (Planned) | 10,000 | $12.83 | $128,300.00 | (17%) 59.97K to 49.97K | 43% |
| 12-Jun-18 4:09 PM View: | Endo International plc (ENDP) | 08-Jun-18 | Grant | 31,291 | -- | -- | 72% 43.7K to 74.99K | |
| 12-Jun-18 4:09 PM View: | Endo International plc (ENDP) | 08-Jun-18 | Payment of Exercise | 15,019 | $7.67 | $115,196.00 | (20%) 74.99K to 59.97K | 5% |
| 04-Jun-18 2:48 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-18 | Grant | 1,555 | $6.43 | $9,998.65 | 4% 38.15K to 39.7K | 17% |
| 02-Mar-18 2:11 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-18 | Grant | 2,012 | $4.97 | $9,999.64 | 6% 36.13K to 38.15K | 52% |
| 04-Dec-17 3:50 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-17 | Grant | 1,968 | $5.08 | $9,997.44 | 6% 34.17K to 36.13K | 48% |
| 05-Sep-17 11:27 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-17 | Grant | 1,960 | $5.10 | $9,996.00 | 6% 32.21K to 34.17K | 48% |
| 12-Jun-17 9:38 PM View: | Endo International plc (ENDP) | 09-Jun-17 | Grant | 23,934 | -- | -- | 77% 31.25K to 55.19K | |
| 12-Jun-17 9:38 PM View: | Endo International plc (ENDP) | 09-Jun-17 | Payment of Exercise | 11,488 | $11.49 | $131,997.00 | (21%) 55.19K to 43.7K | 37% |
| 02-Jun-17 4:01 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jun-17 | Grant | 1,941 | $5.15 | $9,996.15 | 6% 30.27K to 32.21K | 46% |
| 10-Mar-17 10:24 AM View: | Endo International plc (ENDP) | 09-Mar-17 | Market Sale (Planned) | 5,325 | $10.82 | $57,616.50 | (15%) 36.58K to 31.25K | 33% |
| 02-Mar-17 3:05 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-17 | Grant | 1,602 | $6.24 | $9,996.48 | 6% 28.66K to 30.27K | 21% |
| 02-Dec-16 2:06 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-16 | Grant | 1,788 | $5.59 | $9,994.92 | 7% 26.88K to 28.66K | 35% |
| 06-Sep-16 3:25 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-16 | Grant | 2,433 | $4.11 | $9,999.63 | 10% 24.44K to 26.88K | 83% |
| 02-Jun-16 9:45 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 31-May-16 | Grant | 2,581 | $3.39 | $8,749.59 | 12% 21.86K to 24.44K | 122% |
| 03-Mar-16 8:53 PM View: | Endo International plc (ENDP) | 01-Mar-16 | Grant | 7,111 | -- | -- | 22% 32.88K to 39.99K | |
| 03-Mar-16 8:53 PM View: | Endo International plc (ENDP) | 01-Mar-16 | Market Sale | 3,413 | $42.19 | $143,994.00 | (9%) 39.99K to 36.58K | 84% |